To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.


View sample alert

Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Written Question
Department of Health and Social Care: Staff
Thursday 28th March 2024

Asked by: Neil O'Brien (Conservative - Harborough)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what staff networks there are in her Department.

Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)

The following staff-led support networks currently operate in the Department:

- EnABLE, a disability and long-term conditions network;

- Autism Network;

- Attention Deficit Hyperactivity Disorder Network;

- Dyslexia and Dyspraxia Network;

- Race Equality Matters Network;

- Prism, an LGBT+ network;

- Women’s Network;

- Parents’ Network;

- Age Diversity Network;

- Carers’ Network;

- Care Leavers’ Network;

- Social Mobility Network;

- Men’s Health Network;

- Christian Network;

- Jewish Network;

- Muslim Network;

- Hinduism and Sikhism Group;

- Humanists Network;

- Diversity and Inclusion Analytical Network;

- Domestic Abuse Support Group;

- Working Through Cancer Network; and

- Mental Health First Aid.

The following networks support and promote professional development and operational delivery:

- International Network;

- Flexible Working Network;

- Green Network;

- Social Workers Network;

- Health Science and Engineering Network;

- IT User Engagement Group;

- Clinicians’ Network;

- Nutritionist Network;

- Perspectives Network;

- History Network;

- Culture and Engagement Champions Network;

- Active Travel Network;

- International Network;

- First Aid Network;

- Administrative Officer and Executive Officer Network;

- Personal Assistant Network;

- Senior Executive Officer and Higher Executive Officer Network;

- G6 and G7 Network; and

- Direct Appointment Scheme Network.


Written Question
Ovarian Cancer: Diagnosis
Thursday 28th March 2024

Asked by: Tanmanjeet Singh Dhesi (Labour - Slough)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps she is taking to reduce regional variations in early diagnosis of ovarian cancer.

Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)

Reducing inequalities and variation in cancer treatment is a priority for the Government, as is increasing early cancer diagnosis, as both are key contributors to reducing cancer health inequalities. The National Health Service is improving cancer pathways to get people diagnosed faster once referred, and is looking into alternative routes into the system, including non-specific symptom (NSS) pathways for patients who do not fit clearly into a single urgent cancer referral pathway, but who are at risk of being diagnosed with cancer. This will help support faster ovarian cancer diagnosis. 113 NSS pathways are currently operational, with more in development.


Written Question
Tobacco and Vapes Bill
Thursday 28th March 2024

Asked by: Christopher Chope (Conservative - Christchurch)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if she will publish the Regulatory Policy Committee's original opinion on the Tobacco and Vapes Bill submitted to her Department on 12 February 2024; if she will outline the changes she has made to that Bill since receiving that opinion; and what discussions she has had with the Regulatory Policy Committee on the expected timetable for their submission of the revised opinion.

Answered by Andrea Leadsom - Parliamentary Under-Secretary (Department of Health and Social Care)

Smoking is responsible for approximately 80,000 deaths a year in the United Kingdom, and causes around one in four cancer deaths in the UK. It also costs our country £17 billion a year, and puts a huge burden on the National Health Service. That is why we have introduced the Tobacco and Vapes Bill to create the first smokefree generation, and enable us to further crack down on youth vaping. The Tobacco and Vapes Bill is available at the following link:

https://bills.parliament.uk/bills/3703

On 12 February 2024 the Regulatory Policy Committee (RPC) gave opinion on the Tobacco and Vapes Bill impact assessment and rated it green (fit for purpose). However, on 19 March 2024, ahead of the introduction of the bill, a revised version was sent to the RPC for comment. This included changes to reflect the inclusion of Northern Ireland in the bill, following the formation of a Northern Ireland Executive, and a power in the bill to enable the current notification system for nicotine vapes to also cover non-nicotine vapes and other consumer nicotine products, for instance nicotine pouches. The RPC have publicly stated that they welcome the resubmission of the revised impact assessment, and we expect a revised opinion to be issued shortly. The statement from the RPC is available at the following link:

https://www.gov.uk/government/news/the-tobacco-and-vapes-bill-statement-from-the-rpc


Written Question
Tobacco and Vapes Bill
Thursday 28th March 2024

Asked by: Christopher Chope (Conservative - Christchurch)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps her Department is taking to ensure that the Regulatory Policy Committee's revised opinion on the Tobacco and Vapes Bill is published by 16 April 2024.

Answered by Andrea Leadsom - Parliamentary Under-Secretary (Department of Health and Social Care)

Smoking is responsible for approximately 80,000 deaths a year in the United Kingdom, and causes around one in four cancer deaths in the UK. It also costs our country £17 billion a year, and puts a huge burden on the National Health Service. That is why we have introduced the Tobacco and Vapes Bill to create the first smokefree generation, and enable us to further crack down on youth vaping. The Tobacco and Vapes Bill is available at the following link:

https://bills.parliament.uk/bills/3703

On 12 February 2024 the Regulatory Policy Committee (RPC) gave opinion on the Tobacco and Vapes Bill impact assessment and rated it green (fit for purpose). However, on 19 March 2024, ahead of the introduction of the bill, a revised version was sent to the RPC for comment. This included changes to reflect the inclusion of Northern Ireland in the bill, following the formation of a Northern Ireland Executive, and a power in the bill to enable the current notification system for nicotine vapes to also cover non-nicotine vapes and other consumer nicotine products, for instance nicotine pouches. The RPC have publicly stated that they welcome the resubmission of the revised impact assessment, and we expect a revised opinion to be issued shortly. The statement from the RPC is available at the following link:

https://www.gov.uk/government/news/the-tobacco-and-vapes-bill-statement-from-the-rpc


Written Question
Electronic Cigarettes
Wednesday 27th March 2024

Asked by: Rachael Maskell (Labour (Co-op) - York Central)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment she has made of the potential merits of taking steps to create a vape-free generation.

Answered by Andrea Leadsom - Parliamentary Under-Secretary (Department of Health and Social Care)

Smoking is the number one cause of ill-health, disability, and death, responsible for approximately 80,000 deaths a year in the United Kingdom, causing around one in four cancer deaths. It costs our country £17 billion a year, and puts a huge burden on the National Health Service. There is no more dangerous product that is legally sold in our shops than tobacco, a product that will kill two thirds of its users.

The health advice on vaping is clear, vaping can play a role in helping adult smokers to quit, but if you don’t smoke, don’t vape. Vaping should never be used by, or targeted at, children, especially given the highly addictive nature of nicotine.

This is why we have announced strong measures to reduce the appeal, availability, and affordability of vapes to children, whilst ensuring that vapes remain an available quit aid for adult smokers. We will also ban the sale and supply of disposable vapes, which are clearly linked to the recent rise in vaping in children.


Written Question
Oral Cancer: Diagnosis
Wednesday 27th March 2024

Asked by: Jim Shannon (Democratic Unionist Party - Strangford)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what information his Department holds on the number of people diagnosed with mouth cancer in the last twelve months.

Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)

The information requested is not available for the last twelve months. The most recent data available from 2021 shows 9,018 people were diagnosed with mouth cancer in England. Further information is available at the following link:

https://digital.nhs.uk/data-and-information/publications/statistical/cancer-registration-statistics/england-2021---summary-counts-only


Written Question
Brain: Tumours
Wednesday 27th March 2024

Asked by: Lord Hunt of Kings Heath (Labour - Life peer)

Question to the Department of Health and Social Care:

To ask His Majesty's Government how much funding they have allocated for research into the (1) cause, and (2) treatment, of astrocytoma brain tumours in each of the past ten years; and to which organisations and projects and those funds were allocated.

Answered by Lord Markham - Parliamentary Under-Secretary (Department of Health and Social Care)

Research is crucial in tackling cancer, which is why the Department invests over £1 billion per year in health research through the National Institute for Health and Care Research (NIHR). NIHR research expenditure for all cancers was £121.8 million in 2022/23. The NIHR spends more on cancer than any other disease group.

The NIHR funds and supports health, public health and social care research that leads to improved outcomes for patients and the public and makes the health and social care system more efficient, effective, and safe. Research evidence is vital for improving treatments and outcomes for people, including those with astrocytoma brain tumours.

The following table shows NIHR-funded research into astrocytoma brain tumours since 2013/14:

Award Title

Contractor

Start Date

End Date

Status

Total Award Budget

Dabrafenib with trametinib for treating BRAF V600E mutation-positive glioma in children and young people aged 1 to 17 [ID5104]

The University of Sheffield

12/10/2023

12/03/2024

Active

£70,000

A randomized, double-blind, parallel group, placebo-controlled trial of metformin in tuberous sclerosis complex.

University Hospitals Bristol and Weston NHS Foundation Trust

1/8/2012

28/2/2017

Closed

£239,665

Grand total

-

-

-

-

£309,665

The NIHR funds research in response to proposals received from scientists rather than allocating funding to specific disease areas. The NIHR welcomes funding applications for research into any aspect of human health, including astrocytoma brain tumours. It is not usual practice to ring-fence funds for particular topics or conditions. Applications are subject to peer review and judged in open competition, with awards being made based on the importance of the topic to patients and health and care services, value for money and scientific quality.

It is worth noting that all applications that were fundable in open competition have been funded. The Department works closely with research funding partners such as Cancer Research UK and the Medical Research Council, who fund research into new scientific discoveries.


Written Question
Breast Cancer
Tuesday 26th March 2024

Asked by: Tanmanjeet Singh Dhesi (Labour - Slough)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment she has made of the potential impact of breast cancer monitoring devices on global health outcomes.

Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)

The Department has not yet assessed the potential impact of breast cancer monitoring devices. This technology is at an early stage and further evidence is needed before we can assess whether it could be trialled in medical settings.

Improving the early diagnosis of cancer, including breast cancers, is a priority for the National Health Service. NHS England has an ambition to diagnose 75% of cancers at stage one or two by 2028, which will help tens of thousands of people live for longer. NHS England is working to meet the Faster Diagnosis Standard (FDS) which sets a target of 28 days from urgent referral by a general practitioner or screening programme, to patients being told that they have cancer, or that cancer is ruled out.

In January 2022 the Department provided £10 million of funding for 28 new breast screening units and nearly 60 life-saving upgrades to services in the areas where they are most needed, so more women can be checked for signs of cancer, speeding up diagnosis and treatment.


Written Question
Hospitals: Medical Equipment
Tuesday 26th March 2024

Asked by: Rachael Maskell (Labour (Co-op) - York Central)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps she is taking to ensure that (a) medical physicists and (b) clinical engineers have adequate access to advanced (a) radiotherapy and (b) other relevant equipment in hospitals.

Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)

The Government and NHS England work closely together to ensure that staff have access to appropriate equipment, to ensure that cancer patients can receive high quality radiotherapy treatment across England. This includes supporting advances in radiotherapy, using cutting-edge imaging and technology to help target radiation doses at cancer cells more precisely.

The Government has invested in the latest technology in radiotherapy, ensuring that every radiotherapy provider had access to modern, cutting-edge radiotherapy equipment, enabling the rollout of new techniques like stereotactic ablative radiotherapy. The total central investment made between 2016 and 2021 was £162 million, and enabled the replacement or upgrade of approximately 100 radiotherapy treatment machines. Since April 2022, the responsibility for investing in new radiotherapy machines has sat with local systems. This is supported by the 2021 Spending Review, which set aside £12 billion in operational capital for the National Health Service from 2022 to 2025.


Written Question
Cancer: Health Services
Tuesday 26th March 2024

Asked by: Paulette Hamilton (Labour - Birmingham, Erdington)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what discussions she has had with NHS England on the impact of staffing on the (a) National Cancer Patient Experience Survey programme and (b) collection of data on people with pancreatic cancer.

Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)

We are not aware of an impact of staffing on the National Cancer Patient Experience Survey programme, or on the collection of data on people with pancreatic cancer.

The Department is working closely with NHS England to make sure we have the right workforce with the right skills, across the country. In 2023, the National Health Service published the first ever Long Term Workforce Plan, backed by over £2.4 billion of Government funding, to deliver the biggest training expansion in NHS history. Regarding cancer specifically, the number of staff in the cancer workforce has increased by 50% since 2010.

The 2022 National Cancer Patient Experience survey showed respondents’ average rating of care was 8.8 out of 10, with zero being very poor and 10 very good. 75.5% of respondents said they definitely received the right amount of support for their overall health and wellbeing from hospital staff.